Suda Pharmaceuticals Ltd [ASX:SUD] share price and news 2022

Company Description

Suda Pharmaceuticals Ltd (SUD, formerly Suda Ltd) is a drug delivery company utilising proprietary oro-mucosal drug delivery technology to develop low-risk, innovative pharmaceuticals that improve the health and lifestyle of patients. Administering drugs through the oral mucosa, which is the moist lining of the oral cavity (ie: cheeks, tongue, gums and palate), offers ease of use, lower dosage, reduced side effects and faster response time. SUDA operates solely in Australia.

Suda Pharmaceuticals Ltd belongs to Health Care sector and under industry of Pharmaceuticals. You can get more information about this company via their website:

This a small cap company with market cap of 16 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is less than both sector and market. On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 1.75 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how sud dividend grows in the recent years.

No data